CyGenica, a Pune, India and Cork, Ireland-based biotechnology company, raised a $1.4m seed funding round.
The round was led by SOSV, Voyager Health-Tech fund, David Rowan, founder of Voyagers.io, and angel investors Sharaf Yamani, and Sami Mikati.
The company intends to utilize the funds to accelerate the development of its drug delivery technology.
Led by Dr Nusrat Sanghamitra, Co-founder and CEO, CyGenica provides proprietary technology, which enables safe, targeted and affordable intercellular drug delivery. The technology functions like a universal USB drive. It acts as a nanomachine which can deliver multitudes of cargoes carrying molecular information such as drugs and genetic therapeutics in an efficient, targeted manner without any toxicity and minimum immunogenicity.
The company intends to become a key partner of biopharmaceutical companies in the advancement of therapeutics for cancer and rare diseases to improve patient’s health and quality of life.